Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Cryptosporidium infection can cause severe diarrhea with limited treatment options available. Here, Lunde et al. perform a drug repositioning screen with a library of benzoxaboroles and identify AN7973 as potent inhibitor of intracellular parasite development with good efficacy in murine and neonata...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani, Md Mahmudul Hasan, Peter Miller, John Barlow, Yvonne R. Freund, Pamela Berry, Rianna Stefanakis, Jiri Gut, Philip J. Rosenthal, Melissa S. Love, Case W. McNamara, Eric Easom, Jacob J. Plattner, Robert T. Jacobs, Christopher D. Huston
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/9ffc28868e0b404a868e8f4e98e9bbf7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9ffc28868e0b404a868e8f4e98e9bbf7
record_format dspace
spelling oai:doaj.org-article:9ffc28868e0b404a868e8f4e98e9bbf72021-12-02T17:01:37ZIdentification of a potent benzoxaborole drug candidate for treating cryptosporidiosis10.1038/s41467-019-10687-y2041-1723https://doaj.org/article/9ffc28868e0b404a868e8f4e98e9bbf72019-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-10687-yhttps://doaj.org/toc/2041-1723Cryptosporidium infection can cause severe diarrhea with limited treatment options available. Here, Lunde et al. perform a drug repositioning screen with a library of benzoxaboroles and identify AN7973 as potent inhibitor of intracellular parasite development with good efficacy in murine and neonatal dairy calf disease models.Christopher S. LundeErin E. StebbinsRajiv S. JumaniMd Mahmudul HasanPeter MillerJohn BarlowYvonne R. FreundPamela BerryRianna StefanakisJiri GutPhilip J. RosenthalMelissa S. LoveCase W. McNamaraEric EasomJacob J. PlattnerRobert T. JacobsChristopher D. HustonNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Christopher S. Lunde
Erin E. Stebbins
Rajiv S. Jumani
Md Mahmudul Hasan
Peter Miller
John Barlow
Yvonne R. Freund
Pamela Berry
Rianna Stefanakis
Jiri Gut
Philip J. Rosenthal
Melissa S. Love
Case W. McNamara
Eric Easom
Jacob J. Plattner
Robert T. Jacobs
Christopher D. Huston
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
description Cryptosporidium infection can cause severe diarrhea with limited treatment options available. Here, Lunde et al. perform a drug repositioning screen with a library of benzoxaboroles and identify AN7973 as potent inhibitor of intracellular parasite development with good efficacy in murine and neonatal dairy calf disease models.
format article
author Christopher S. Lunde
Erin E. Stebbins
Rajiv S. Jumani
Md Mahmudul Hasan
Peter Miller
John Barlow
Yvonne R. Freund
Pamela Berry
Rianna Stefanakis
Jiri Gut
Philip J. Rosenthal
Melissa S. Love
Case W. McNamara
Eric Easom
Jacob J. Plattner
Robert T. Jacobs
Christopher D. Huston
author_facet Christopher S. Lunde
Erin E. Stebbins
Rajiv S. Jumani
Md Mahmudul Hasan
Peter Miller
John Barlow
Yvonne R. Freund
Pamela Berry
Rianna Stefanakis
Jiri Gut
Philip J. Rosenthal
Melissa S. Love
Case W. McNamara
Eric Easom
Jacob J. Plattner
Robert T. Jacobs
Christopher D. Huston
author_sort Christopher S. Lunde
title Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
title_short Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
title_full Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
title_fullStr Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
title_full_unstemmed Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
title_sort identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/9ffc28868e0b404a868e8f4e98e9bbf7
work_keys_str_mv AT christopherslunde identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT erinestebbins identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT rajivsjumani identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT mdmahmudulhasan identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT petermiller identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT johnbarlow identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT yvonnerfreund identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT pamelaberry identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT riannastefanakis identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT jirigut identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT philipjrosenthal identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT melissaslove identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT casewmcnamara identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT ericeasom identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT jacobjplattner identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT roberttjacobs identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
AT christopherdhuston identificationofapotentbenzoxaboroledrugcandidatefortreatingcryptosporidiosis
_version_ 1718382099200737280